Viewing Protocol Section

Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section


Ignite Creation Date: 2024-05-06 @ 6:40 PM
Last Modification Date: 2024-10-26 @ 2:52 PM
Study NCT ID: NCT05745350
Protocol Section: NCT05745350
Start Identification Module Data
Brief Title: First Line Pembrolizumab Plinabulin Plus Etoposide and Platinum EP for ES-SCLC
Official Title: An Open-Label Single-Arm Phase II Study of Pembrolizumab Plinabulin Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer
Acronym: None
Organization: Wuhan Union Hospital China
Organization Class: OTHER
Organization Study ID: KeyPemls-005
Start Status Module Data
Status Verified Date: 2023-11
Overall Status: NOT_YET_RECRUITING
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Xiaorong Dong
Lead Sponsor Class: OTHER
Lead Sponsor: Xiaorong Dong
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload